Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication-Reference-Cited by-同舟云学术

Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication

Published:2017-04 Issue:2 Volume:66 Page:206-220.e9
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Foskolou Iosifina P.,Jorgensen Christian,Leszczynska Katarzyna B.,Olcina Monica M.,Tarhonskaya Hanna,Haisma Bauke,D’Angiolella Vincenzo,Myers William K.,Domene Carmen,Flashman Emily,Hammond Ester M.

Funder

Cancer Research UK (CR-UK)

CR-UK Oxford Centre Prize DPhil Studentship

King’s College London GTA

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference104 articles.

1. Allosteric inhibition of human ribonucleotide reductase by dATP entails the stabilization of a hexamer;Ando;Biochemistry,2016

2. Clofarabine 5′-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit;Aye;Proc. Natl. Acad. Sci. USA,2011

3. Clofarabine targets the large subunit (α) of human ribonucleotide reductase in live cells by assembly into persistent hexamers;Aye;Chem. Biol.,2012

4. Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species;Aye;J. Biol. Chem.,2012

5. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies;Aye;Oncogene,2015

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental signals control chromosome segregation fidelity during pluripotency and neurogenesis by modulating replicative stress;Nature Communications;2024-08-28

2. Characterising cancer cell responses to cyclic hypoxia using mathematical modelling;2024-06-26

3. Neuronal DNA repair reveals strategies to influence CRISPR editing outcomes;2024-06-26

4. Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities;Seminars in Cancer Biology;2024-01

5. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy;Seminars in Cancer Biology;2023-12